The recent dilution is essentially the completion of Pharming’s recapitalization that has been going on for some time. Given the crushing near-term debt load Pharming had to contend with, investors should hardly be surprised by the recent dilution.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”